filmov
tv
The HER Pathway and Cancer
Показать описание
Genentech VP of Clinical Oncology Dietmar Berger discusses the role of the HER2 receptor in metastatic breast cancer.
Genentech
Breast
Cancer
Gene
Expressions
Genentech
Рекомендации по теме
0:04:33
The HER Pathway and Cancer
0:03:09
HER2 in Cancer
0:01:27
Deciphering the Role of PI3K Mutations in HER2+ Breast Cancer
0:08:17
Metastatic gastric cancer: Indications and impact of targeting the HER2 pathway?
0:16:38
The HER-2 Pathway in GI Cancer
0:46:00
Advanced Breast Cancer: Challenges in Pathways Development
0:31:21
Novel Therapeutics for Breast Cancer: HER2+ and Triple Negative Disease; New Pathways, Targets
0:08:24
Understanding Breast Cancer
0:01:28
Estrogen signaling in breast cancer
0:03:57
The Met Signaling Pathway and Cancer
0:51:40
Optimizing Treatment Options for HER2+/ ER+ Breast Cancer using Models of Endocrine Resistance
0:33:17
Signaling Pathways in Cancer Symposium: Joan Brugge
0:21:19
Estrogen Receptors & HER2/neu Receptors in Breast Cancer (a TUTORIAL from Oster Oncology)
0:59:38
What's New and on the Horizon for Metastatic Breast Cancer?
0:08:26
Breast Cancer Receptors: Learn What You Need to Know
0:08:13
Clinical usage of antibody: Herceptin (Antibody as breast cancer medicine)
0:25:14
Metastatic HER2 Negative Breast Cancer: Emerging Novel Treatment Strategies
0:39:01
Cancer evolution through space and time - Prof Charles Swanton - UCL LHL
0:04:51
Breast Cancer Genes and Mutations
0:40:27
Integrating Novel Developments for Advanced and Metastatic Breast Cancer into Improved Care Pathways
0:08:41
Ras Raf MAPK Pathway and Cancer | Mutations, Cancer Pathogenesis, and Chemotherapy
0:31:50
Signaling Pathways in Cancer Symposium: William Kaelin
0:02:20
HER2 in Gastric Cancer
0:23:48
Chemical Biology of Innate Immune Checkpoints of the Anti-Cancer cGAMP-STING Signaling Pathway